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T cell receptor (TCR) recognition is intrinsically polyspeciﬁc. In the ﬁeld of autoimmunity,
recognition of both self- and microbial peptides by a single TCR has led to the concept of
molecular mimicry. However, ﬁndings made by our group and others clearly demonstrate
that a given TCR can also recognize multiple distinct self-peptides. Based on experimen-
tal data we argue that recognition of several self-peptides increases the pathogenicity of
an autoreactive T cell; a property we refer to as “cumulative autoimmunity.” The mecha-
nisms of such increased pathogenicity, and the implications of cumulative autoimmunity
regarding the pathophysiology ofT cell-mediated autoimmune diseases will be discussed.
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POLYSPECIFICITY OF AUTOREACTIVE T CELLS IS NOT
LIMITED TO RECOGNITION OF EXOGENOUS ANTIGENS
Both theoretical considerations (Mason, 1998) and experimental
evidence (Wucherpfennig and Strominger, 1995) strongly sup-
port the idea that polyspeciﬁcity is an intrinsic property of T
cell receptor (TCR) recognition. A single TCR has been shown
to recognize different peptides in the context of either the same,
or different MHC molecules (Sospedra et al., 2006). Moreover,
single amino acid substitutions involving TCR-contact residues
of an antigenic peptide (so-called altered peptide ligands) can
lead to markedly different TCR signaling and T cell functions
(Sloan-Lancaster and Allen, 1996). The molecular basis for TCR
polyspeciﬁcity is currently ill-deﬁned but efforts in resolving the
structures of MHC:peptide (pMHC) complexes have provided
insight into possible mechanisms (Yin and Mariuzza, 2009). In
the ﬁeld of autoimmunity TCR polyspeciﬁcity has mostly been
viewed in the context of molecular mimicry. The latter poses
that autoimmune diseases can be triggered by microbes follow-
ing lymphocyte cross-recognition of microbial- and self-derived
peptides (Wucherpfennig and Strominger, 1995; Münz et al.,
2009). Reports have shown in animal models of multiple sclerosis
(MS) and type 1 diabetes (T1D) for instance, that self-tolerance
is broken by activation of autoreactive T cells following TCR
recognition of microbial antigens (Gautam et al., 1998; Harkio-
laki et al., 2009; Münz et al., 2009). This ability of the TCR to
recognize multiple peptides likely provides advantage to the indi-
vidual despite its inherent risk of autoimmunity. For instance,
TCR polyspeciﬁcity would be expected to limit the likelihood of
“holes in the repertoire” and, thereby, enhance host immunity to
pathogens.
A number of recent studies indicate that single TCR also
bind to distinct self-peptides from different autoantigens or
non-overlapping peptides derived from the same autoantigen.
For instance, a study demonstrated that CD4+ T cells cloned
from peripheral blood of healthy subjects and expanded in
an autologous-mixed lymphocyte response recognize multiple
autoantigenic epitopes (Cai and Haﬂer, 2007). The epitopes rec-
ognized by these CD4+ T cell clones include a panel of peptides
derived from autoantigens associated with T1D and MS such
as glutamic acid decarboxylase (GAD), insulin, proinsulin, and
myelin basic protein (MBP). Interestingly, the majority of CD4+
T cell clones speciﬁc for viral-derived epitopes lacked signiﬁcant
polyspeciﬁcity, suggesting that the recognition of multiple epi-
topes is more common among autoreactive T cell clonotypes
(Cai and Haﬂer, 2007). It is, however, worth noting that T cells
speciﬁc for foreign antigens in order to be positively selected in
the thymus interact with endogenous self-peptides:MHC com-
plexes, at least with very low afﬁnity (Juang et al., 2010). Londei
and colleagues (Quaratino et al., 1995) reported that an HLA-
DQ6-restricted self-reactive CD4+ T cell clone established from
the thyroid inﬁltrate of a patient with Graves’ disease responded
in vitro to two overlapping peptides from thyroid peroxidase
(peptides 536–545 and 540–548). Molecular modeling led to the
hypothesis that the two DQ6:self-peptide complexes generated
similar antigenic surfaces in terms of conformation and charge for
this polyspeciﬁc TCR. A study evaluated the breadth of peptide
ligands recognized by a DR2 (DRB1*1501)-restricted MBP86–
96 speciﬁc CD4+ T cell clone established from the blood of an
MS patient using combinatorial peptide libraries (Hemmer et al.,
1997). Based on this analysis, a number of stimulatory peptides
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derived from self-proteins could be predicted that were then con-
ﬁrmed experimentally. Interestingly, some of these self-peptides
induced an enhanced T cell response compared to the “cognate”
MBP peptide and therefore exhibited heteroclitic behavior. A sim-
ilar analysis of CD4+ T cell clones derived from the cerebro-spinal
ﬂuid (CSF) of an MS patient during disease exacerbation identi-
ﬁed stimulatory peptides from both common human viruses and
several self-proteins expressed in the central nervous system (CNS;
Sospedra et al., 2005). Polyspeciﬁcity has also been demonstrated
within the CD8+ T cell compartment. CD8+ T clones speciﬁc for
Melan-A, a melanocyte differentiation and tumor-associated anti-
gen, originating from different HLA-A2 individuals were found to
recognize multiple self-peptides. Furthermore, public patterns of
self-polyspeciﬁcity, as well as private ones, were identiﬁed among
these clones (Dutoit et al., 2002).
Finally,work by our groupdemonstrated polyspeciﬁcity among
β cell-speciﬁc CD4+ T cell clones derived from non-obese diabetic
(NOD) mice, a spontaneous model of T1D (Li et al., 2008). A sub-
stantial number of CD4+ T cell clones established with GAD65
protein recognized dual epitopes that were non-overlapping and
had distinct amino acid sequences. Importantly, these T cell
clones expressed a single TCR, and an engineered soluble poly-
speciﬁc TCR was shown to interact with complexes of soluble
I-Ag7 and the respective GAD65-derived peptides. Notably, some
CD4+ T cell clones also exhibited inter-molecular polyspeciﬁcity
by responding to GAD65 and to other β cell-derived autoantigens,
further demonstrating that various forms of TCR polyspeciﬁcity
exist. Collectively these ﬁndings demonstrate that several examples
of polyspeciﬁcity toward self-antigens exist among autoreactive T
cells in both humans and mice, arguing that this property may in
fact be important for driving T cell-mediated autoimmunity.
WHAT IS THE MOLECULAR BASIS FOR POLYSPECIFICITY?
The extent of TCR polyspeciﬁcity is very likely to be underesti-
mated and therefore the epitopes that have been deﬁned reﬂect
only a portion of the cross-reactive self-peptide pool. Recogni-
tion of a peptide by a polyspeciﬁc TCR is nevertheless speciﬁc.
For example, recognition by polyspeciﬁc T cell clones is sensitive
to subtle structural changes in the peptide (Hagerty and Allen,
1995; Maynard et al., 2005), similar to that typically observed for
monospeciﬁc T cell clones. Given the necessity of polyspeciﬁcity
for thymic positive selection and its presumed importance for
immune defense, the structural basis for this inherent property
of the TCR has been investigated at the atomic level. Germline-
encoded TCR CDR1 and CDR2 loops contact mainly the MHC
helices,whereas theCDR3 loops interact with the side chains of the
peptide. Cross-reactivity has been shown to rely on several alter-
native structural solutions (Wucherpfennig et al., 2007; Yin and
Mariuzza, 2009). Structural mimicry has been well illustrated by
the interactions deﬁned between the MBP-speciﬁc Ob.1A12 TCR
and a naturally processed E. coli peptide presented by the same
HLA-DR2b molecule. In both cases, the binding footprint of the
TCR is similar involving shared P2 and P3 TCR-contact residues
(Harkiolaki et al., 2009). Analogous docking topologies have also
been observed for a TCR interacting with a viral and a self-antigen
bound to HLA-A2 (Borbulevych et al., 2011), and for a TCR bind-
ing self and allogenic MHC molecules (Yin and Mariuzza, 2009).
A given TCR can also adopt large conformational changes of
one CDR3 loop to productively interact with different peptides,
with little or no sequence sharing, presented by the same MHC
molecule (Reiser et al., 2003). Conformational ﬂexibility of the
peptide:MHC complex upon ligation with the TCR can also con-
tribute to cross-reactivity. Studies have demonstrated that there
can be a signiﬁcant amount of ﬂexibility in MHC-bound peptide
side chains and backbone (Dessen et al., 1997; Sharma et al., 2001;
Fremont et al., 2002). Accordingly, peptides exhibiting enhanced
ﬂexibility may readily adopt a conformation that enhances poly-
speciﬁc recognition by a T cell clone. More drastic differences in
binding strategymay also underlie recognition of two distinct pep-
tide:MHC complexes by a given TCR. Indeed, the 2C TCR adopts
very distinct orientation to interact with the allo H-2Ld:QL9 com-
plex or with the H-2Kb:self-peptide complex (Colf et al., 2007).
Weak interactions between the autoreactive 3A6 TCR and cog-
nate HLA-DR2a:MBP84–102 ligand, which lack hydrogen bonds
or salt bridges linking theTCRand theMBPpeptide,are thought to
result in a higher degree of tolerance for substituted peptides and,
therefore, to promote cross-reactivity (Yin and Mariuzza, 2009).
MHC polymorphism has also been shown to inﬂuence pep-
tide ﬂexibility (Pöhlmann et al., 2004). With this in mind, one
intriguing possibility is that MHC alleles associated with increased
autoimmune susceptibility permit increased mobility of bound
peptides, thereby promoting T cell polyspeciﬁcity. On the other
hand, TCR polyspeciﬁcity can include recognition of multiple
MHCmolecules as noted above for alloreactive TCR.More impor-
tant for autoimmunity is the possibility of an autoreactive TCR to
productively engage different MHC molecules expressed by the
individual. For instance, the Hy.2E11 TCR originating from an
MS patient recognizes both MBP85–99 bound to HLA-DR2b and
an Epstein–Barr virus peptide bound to HLA-DR2a; both DR2
molecules being encoded by the same haplotype. Crystal struc-
ture determination of these two MHC:peptide complexes revealed
marked structural similarity for TCR recognition (Lang et al.,
2002). A given TCR may even bind to both MHC class I: and class
II:peptide complexes. Structural analysis of such a case led to the
surprising observation that the TCR adopts different conforma-
tions to interact with the two ligands. A “standard” TCR binding
mode occurs with the MHC class II:peptide complex, whereas
the CDR1 and CDR2 loops of the Vα chain are displaced from
the Vα CDR3 loop and Vβ loops when the TCR is bound to the
MHC class I:peptide complex (Yin et al., 2011). The ability of a
given TCR to exhibit multiple conformations is likely to further
enhance polyspeciﬁcity.
The properties of TCR speciﬁc for multiple self-peptides
remain ill-deﬁned. Clues into the latter have come from crystal
structures of autoreactive TCR. For instance, the study of a murine
MBP-speciﬁc TCR indicates structural plasticity in TCR binding
of the pMHCcomplex (Maynard et al., 2005). This plasticity facili-
tates alternative structural solutions for engagement by the autore-
active TCR. Therefore polyspeciﬁcity may reﬂect an enhanced
capacity of a given TCR to accommodate alternative binding solu-
tions coupled with increased conformational adaptability of a
peptide bound by MHC. Alternatively, reduced surface of inter-
action between the TCR and the self-peptide may offer greater
opportunity for cross-reactivity (Sethi et al., 2011). Interestingly,
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GAD65-polyspeciﬁc CD4+ T cell clones display an increased rel-
ative TCR afﬁnity compared to the corresponding monospeciﬁc
CD4+ T cell clones (Li et al., 2008). For example, relative TCR
afﬁnity for a given epitope can be increased by approximately ﬁve-
fold between GAD65-polyspeciﬁc (KD = 15.1± 2.8 nmol/l) ver-
sus -monospeciﬁc (KD = 76.7± 16.9 nmol/l) CD4+ T cell clones
(Li et al., 2008). Increased TCR afﬁnity has been reported to cor-
relate with enhanced cross-reactivity, due to ﬂexibility in the CDR
loops that bind the pMHC complex (Garcia et al., 1998; Holler
et al., 2003; Reiser et al., 2003). Whether increased avidity/afﬁnity
is a common property of polyspeciﬁc TCR is an important issue
that needs to be resolved.
THYMIC DEVELOPMENT OF POLYSPECIFIC AUTOREACTIVE
T CELLS
How do polyspeciﬁc autoreactive T precursors develop in the thy-
mus? Recognition of multiple self-peptides presented by thymic
APC would a priori be expected to enhance deletion of the corre-
sponding thymocytes due to increased pMHC complexes to drive
negative selection. One explanation is that polyspeciﬁc autoreac-
tive T precursors express TCR with reduced afﬁnity therefore lim-
iting the efﬁcacy of negative selection, despite sufﬁcient numbers
of pMHC complexes. However, as noted above at least some poly-
speciﬁcTCRexhibit increased avidity/afﬁnity relative tomonospe-
ciﬁc TCR. Low thymic expression of tissue speciﬁc-antigens, and
aberrant processing and/or presentation of self-peptides may be
key factors favoring the development of polyspeciﬁc autoreactive
thymocytes. How polyspeciﬁc autoreactive T cells escape central
tolerance is an important area for future study.
Other factors associated with the polygenic nature of autoim-
mune diseases are likely to contribute aswell to the development of
polyspeciﬁc autoreactive T cells. Several gene polymorphisms have
been associated with autoimmunity affecting molecules involved
in TCR signaling. This could impact intra-thymic differentiation
and selection of polyspeciﬁc (as well as monospeciﬁc) self-reactive
T precursors. For instance, the gain-of-function variant (R620W)
of the PTPN22 phosphatase, which has been linked to a number
of autoimmune diseases, limits the magnitude of TCR signal-
ing needed to promote negative selection of autoreactive (e.g.,
polyspeciﬁc) thymocytes (Vang et al., 2005). Similarly polymor-
phisms in the gene encoding Vav1, an enzyme that catalyzes the
exchange of guanine nucleotides on Rho/Rac proteins in TCR sig-
naling, are associated with susceptibility to experimental autoim-
mune encephalomyelitis (EAE) and MS, and may affect thymic
differentiation of autoreactive T precursors by either impairing
negative selection and/or commitment to the Foxp3-expressing
CD4+ T cell lineage (Jagodic et al., 2009). It is conceivable that
Foxp3-expressing regulatory CD4+ T cells (Tregs) also express
polyspeciﬁc TCR due to enriched self-reactive speciﬁcities (Wing
and Sakaguchi, 2010). The extent of polyspeciﬁcity among Tregs is
currently unknown. Polyspeciﬁcity for self-antigens may enhance
the likelihood of Treg activation by effectively increasing the den-
sity of TCR ligands at a given site and/or provide more sites
for productive TCR:MHC:self-peptide interactions. Since Treg-
mediated suppression is independent of the speciﬁcity of effector
T cells, polyspeciﬁcity would be expected to expand the functional
potency of Tregs. Further research should clarify whether Tregs
with polyspeciﬁcity for self-antigens are more protective against
autoimmunity as compared to monospeciﬁc Tregs.
POLYSPECIFICITY OF AUTOREACTIVE T CELLS CONFERS
ENHANCED PATHOGENICITY: THE CONCEPT OF CUMULATIVE
AUTOIMMUNITY
The pathogenicity of T cells recognizing multiple self-epitopes
has recently been examined in NOD mice and a spontaneous
transgenic model of EAE. The latter model relies on 2D2-TCR
mice, which are transgenic for a TCR speciﬁc for the myelin-
oligodendrocyte glycoprotein (MOG) 35–55 peptide presented
by I-Ab on the C57BL/6 genetic background (Bettelli et al.,
2003). Unexpectedly, 2D2-TCR mice crossed with MOG-deﬁcient
(MOG−/−) animals spontaneously develop EAE despite the lack
of the target myelin autoantigen [30]. The incidence, kinetics,
clinical, and histological manifestations of spontaneous EAE are
indistinguishable from that observed in MOG-expressing 2D2-
TCR transgenic mice. To explain this paradoxical phenotype, we
hypothesized that the clonotypic 2D2-TCR recognizes a neural
antigen other than MOG, leading to CNS inﬂammation. Using a
biochemical approach,neuroﬁlament-medium(NF-M),an axonal
protein, was identiﬁed as an additional self-antigen recognized by
the 2D2-TCR (Krishnamoorthy et al., 2009; Figure 1). Impor-
tantly, MOG35–55-reactive CD4+ T cells from non-transgenic
mice also exhibit in vitro reactivity to theNF-Mpeptide,both at the
population and clonal levels. In addition, the MOG35–55-speciﬁc
2D2 CD4+ T cells are activated by CNS extracts from MOG−/−
but notMOG−/− ×NF-M−/− KOanimals, indicating that theNF-
M peptide is processed and presented by APC (Krishnamoorthy
et al., 2009).
Since 2D2 CD4+ T cells recognize two distinct self-antigens
it was possible to assess the inﬂuence of TCR polyspeciﬁcity on
the pathogenic potential of these T cells in vivo. CD4+ Th1 cells
from 2D2-TCR RAG−/− donor mice were injected into wild-
type, as well as NF-M−/−,MOG−/−, or MOG−/− ×NF-M−/− KO
mice, which exhibit no clinical or histological abnormalities at a
young age (Jacomy et al., 1999; Delarasse et al., 2003). As expected,
recipient mice expressing the two autoantigens (wild-type mice)
rapidly developed lethal EAE. Conversely, mice lacking the two
autoantigens (MOG−/− ×NF-M−/− KO mice) remained free of
CNS inﬂammation. Notably, MOG−/− KO mice presented an
intermediate phenotype, suggesting that recognition of MOG and
NF-M by the 2D2 CD4+ T cells contribute to disease phenotype
and severity (Krishnamoorthy et al., 2009). We refer to this novel
observation as “cumulative autoimmunity” to designate autoreac-
tive T cell clones that target more than one cognate self-epitope
and consequently exhibit additive (or synergistic) pathogenicity.
Cumulative autoimmunity is also seen with GAD65-polyspeciﬁc
versus monospeciﬁc CD4+ T cell clones, which exhibit increased
pathogenicity upon adoptive transfer into NOD.scid recipients (Li
et al., 2008).
HOW DOES TCR POLYSPECIFICITY INFLUENCE THE
PATHOGENICITY OF AUTOREACTIVE T CELLS AND
CUMULATIVE AUTOIMMUNITY?
Polyspeciﬁcity would be predicted to inﬂuence the pathogenicity
of autoreactive T cells in a number of ways. This would include
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FIGURE 1 | Schematic representation of the possible structural
bases underlying the dual specificity of 2D2T cells for MOG38–50
and NF-M18–30.The core region of the MOG38–50 peptide ranges from
Y40 to V47 and contains the amino acids at position 41, 44, 46, and 47,
which are known to be the contact amino acids for the 2D2-TCR and
other MOG-speciﬁc T cell lines (Petersen et al., 2004; Ben-Nun et al.,
2006). These amino acids are preserved at identical positions in
NF-M18–30. The NF-M18–30 (TETRSSFSRVSGS) and the MOG38–50
(GWYRSPFSRVVHL) epitopes therefore share keyTCR-contact residues
(marked by arrows pointing upward) when presented in the context of
I-Ab. The residues of the respective peptides interacting with the P1 P4,
P6, and P9 pockets of the I-Ab are also indicated. Interestingly, although
both peptides induce activation of CD4+ T cells from 2D2-TCR RAG−/−
mice, the agonistic potential of NF-M18–30 peptide exceeds that of the
MOG38–50 peptide, as revealed by proliferation and cytokine release
assays.
affecting the extent of: (i) T cell survival, activation, expansion,
and differentiation, and (ii) T cell-mediated tissue destruction.
Polyspeciﬁcity for self-peptides may promote enhanced periph-
eral survival and therefore persistence of the pool of autoreactive
mature T cells (Wucherpfennig and Gagnon, 2009). Similarly, T
cell clones exhibiting inter- or intra-molecular polyspeciﬁcity for
a given tissue or autoantigen could have an advantage for clonal
expansion. For instance, simultaneous recognition of multiple epi-
topes presented by APC may increase the local concentration of
stimulatory peptides and induce efﬁcient T cell activation, subse-
quent expansion and tissue retention (Cabbage et al., 2007; Lennon
et al., 2009). An increased frequency of GAD65-polyspeciﬁc ver-
sus -monospeciﬁc CD4+ T cell clones residing in the pancreatic
lymph nodes and islets of NOD female mice (Li et al., 2008) is con-
sistent with such a scenario. As noted above, GAD65-polyspeciﬁc
versus -monospeciﬁc CD4+ T cell clones have an increased rel-
ative TCR afﬁnity suggesting that polyspeciﬁcity may prove to
be a key factor contributing to the avidity/afﬁnity maturation of
autoreactive T effectors as autoimmunity progresses. Noteworthy
is that increased avidity/afﬁnity is a property of highly patho-
genic β cell-speciﬁc T cells in NOD mice (Amrani et al., 2000).
Whether these effector T cells exhibit β cell polyspeciﬁcity needs
to be explored.
It is also conceivable that activated autoreactive T cells speciﬁc
for one self-peptide are prone to react to a different self-peptide,
due to a reduced activation threshold (Kimachi et al., 2003). T cells
speciﬁc for multiple self-antigens could therefore be stimulated by
the simultaneous or successive recognition of several self-peptides
by local APC with a decreased dependence on co-stimulatory
signals. The latter would be reﬂected by “epitope spread” which
has been reported for the progression of various T cell-mediated
autoimmune diseases (Lehmann et al., 1993). One interesting sce-
nario is that distinct pMHC complexes presented by the sameAPC
(or APC in the same micro-environment) adopt different struc-
tures, thereby eliciting different T cell signaling events. Since the
Table 1 | Parameters governing the pathogenic potential of
autoreactiveT cells.
Parameter Outcome(s) Selected references
Number Increased numbers of
autoreactive T cells correlates
with enhanced disease severity
Zamvil et al. (1985),
Vizler et al. (2000)
T cell
lineage
The expression of chemokine
receptors, integrins, cytokines,
and death-promoting molecules
inﬂuences trafﬁcking to and the
pathogenicity of autoreactive T
cells in the target tissue
Jäger et al. (2009),
Charo and Ransohoff
(2006), Reboldi et al.
(2009)
T cell afﬁn-
ity/avidity
IncreasedTCR afﬁnity and/or T
cell avidity correlates with an
elevated pathogenic potential
for autoreactive T cells
Amrani et al. (2000),
Tsai et al. (2008),
Lyman et al. (2005),
Garcia et al. (2001)
Polyspeciﬁcity T cells recognizing multiple
self-peptides exhibit increased
pathogenicity
Li et al. (2008),
Krishnamoorthy et al.
(2009)
TCR strength of signal inﬂuences commitment into the various
T cell subsets, polyspeciﬁcity could have a direct bearing on the
functional properties of autoreactive T cells and thereby on their
propensity to initiate tissue damage.
T cell receptor polyspeciﬁcity broadens the repertoire of self-
epitopes that may lead to diversiﬁcation of cellular and anatomical
targets, and consequently increase the severity of autoimmu-
nity. For example, MOG is speciﬁcally expressed in CNS myelin,
whereas NF-M is part of the axonal/neuronal cytoskeleton in both
the CNS and peripheral nervous system (PNS). Accordingly, 2D2
CD4+ T cells typically induce inﬂammation in structures of both
the PNS and CNS resulting in a more severe neurological pheno-
type. Alternatively,when several peptides from a given self-antigen
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or from antigens from the same anatomical structure are recog-
nized, the increased pMHC ligand density in the targeted tissue is
a likely basis by which the cross-reactive self-speciﬁc T cells exert
enhanced pathogenic property (Li et al., 2008). This is potentially
important since within target tissues the MHC molecules are not
saturated by a given self-peptide and increased self-antigen avail-
ability can enhance local T cell activation and exacerbate disease
(Odoardi et al., 2007).
CONCLUDING REMARKS
It is clear that murine and human autoreactive T cells exhibit
speciﬁcity for multiple self-derived epitopes. Polyspeciﬁcity for
self-antigens appears one of the parameters inﬂuencing the path-
ogenic potential of autoreactive T cells (Table 1). Based on our
ﬁndings we argue that polyspeciﬁcity enhances the pathogenicity
of autoreactiveT cells through anumber of possible scenarios lead-
ing to cumulative autoimmunity. The activation and expansion of
polyspeciﬁc T cells may also partly explain critical events thought
to drive T cell-mediated autoimmunity such as epitope spread
and avidity/afﬁnity maturation of autoreactive T cells. Neverthe-
less, signiﬁcant work is still needed to determine the contribution
of polyspeciﬁc autoreactive T cells and cumulative autoimmunity
in the initiation and progression of self-tissue destruction. For
instance, the frequency of autoreactive T cells displaying poly-
speciﬁcity, and the properties of the peptides and corresponding
TCR that promote polyspeciﬁcity are key issues that need further
study. Finally, targeting polyspeciﬁc autoreactive T cells may prove
to be an effective strategy for immunotherapy. For instance, the
target pool of autoreactive T precursors and/or effectors would be
increased with administration of a self-peptide that is recognized
by polyspeciﬁc T cells. Indeed, work by our group showed that the
most potent GAD65-speciﬁc peptides at inducing immunoregu-
latory T effectors to suppress β cell autoimmunity in NOD mice
were epitopes recognized by polyspeciﬁc CD4+ T cells (Tisch et al.,
1999).
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